Soley Therapeutics News and Activities

Acquisition, funding and merger involving Soley Therapeutics.

• Soley Therapeutics has just announced a $200 Million fundraising (posted on January 9 2026).

View the org chart displaying its 13 main executives

Most searched biographies at Soley Therapeutics

• Yerem Yeghiazarians, Chief Executive Officer
• Sung You, Director
• Jim Breyer, Director

Popular executive movements at Soley Therapeutics

• Berthil Clasen has joined the company as Chief Business Officer  (posted on June 9 2026).
• Sheerin Latham, Head, Non-Clinical Drug Development, has left the company  (posted on June 9 2026).

Create your alert
to follow the executive moves at Soley Therapeutics.

Soley Therapeutics has 2,430 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Tempus has announced the acquisition of Personalis  (posted on July 20 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Soley Therapeutics

• News - Soley Therapeutics

Social media about Soley Therapeutics

• Soley Therapeutics on Wikipedia, Google News & Yahoo Finance
• Soley Therapeutics on LinkedIn, X (Twitter) & YouTube